Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for TRxADE HEALTH, Inc. (MEDS : NSDQ)
 
 • Company Description   
TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group Inc., is based in TAMPA, FL.

Number of Employees: 47

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.46 Daily Weekly Monthly
20 Day Moving Average: 28,092 shares
Shares Outstanding: 8.18 (millions)
Market Capitalization: $11.94 (millions)
Beta: 1.36
52 Week High: $9.49
52 Week Low: $1.16
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.26% -16.19%
12 Week -21.08% -15.01%
Year To Date -38.14% -24.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2420 Brunello Trace
-
Lutz,FL 33558
USA
ph: 800-261-0281
fax: 800-265-6932
ir@trxade.com http://www.trxade.com
 
 • General Corporate Information   
Officers
Suren Ajjarapu - Chairman and Chief Executive Officer
Prashant Patel - President and Chief Operating Officer
Howard A. Doss - Chief Financial Officer
Donald G. Fell - Director
Charles L. Pope - Director

Peer Information
TRxADE HEALTH, Inc. (CHCR)
TRxADE HEALTH, Inc. (ESRX)
TRxADE HEALTH, Inc. (MYDP)
TRxADE HEALTH, Inc. (GBCS)
TRxADE HEALTH, Inc. (LAXAF)
TRxADE HEALTH, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 89846A207
SIC: 5122
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/25/22
Share - Related Items
Shares Outstanding: 8.18
Most Recent Split Date: 2.00 (0.17:1)
Beta: 1.36
Market Capitalization: $11.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.32 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 20.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/25/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.14
Price/Cash Flow: -
Price / Sales: 1.19
EPS Growth
vs. Year Ago Period: -50.00%
vs. Previous Quarter: -33.33%
Sales Growth
vs. Year Ago Period: 6.13%
vs. Previous Quarter: 35.68%
ROE
03/31/22 - -73.00
12/31/21 - -50.16
09/30/21 - -63.53
ROA
03/31/22 - -51.87
12/31/21 - -40.27
09/30/21 - -54.35
Current Ratio
03/31/22 - 2.25
12/31/21 - 4.72
09/30/21 - 7.92
Quick Ratio
03/31/22 - 2.08
12/31/21 - 4.66
09/30/21 - 7.78
Operating Margin
03/31/22 - -30.91
12/31/21 - -28.38
09/30/21 - -45.64
Net Margin
03/31/22 - -55.82
12/31/21 - -53.76
09/30/21 - -72.07
Pre-Tax Margin
03/31/22 - -55.88
12/31/21 - -53.76
09/30/21 - -72.04
Book Value
03/31/22 - 0.35
12/31/21 - 0.46
09/30/21 - 0.57
Inventory Turnover
03/31/22 - 38.13
12/31/21 - 27.06
09/30/21 - 11.94
Debt-to-Equity
03/31/22 - 0.12
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 10.34
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©